Status
Conditions
Treatments
About
A structured group art therapy intervention, comprising six 60 - 90-minute weekly workshops.
Full description
The CHArt group art therapy intervention builds on a 6-week art therapy group intervention piloted with Barts Health oncology and palliative care doctors (Tjasink, M. 2019). It incorporates elements of workshops delivered for staff support by Barts art therapists during the Covid-19 pandemic (Tjasink, M., Stevens, P. 2022).
The intervention is broadly informed by affective neuroscience and evolutionary psychology theories with an emphasis on compassion-focused and resource-oriented therapeutic practice. Whilst the intervention draws on diverse influences, it aligns with the principles of Compassion Focussed Therapy (CFT), an integrative, bio-physiological psychological model underpinned by evolutionary theory.
Intervention elements include psycho-education, individual art making, collaborative group art making, art making in pairs, exploring a range of art materials and techniques (including clay, paint, natural objects and non-traditional mark - making materials), art-based grounding exercises and reflective discussion.
The intervention manual was developed by the study's Chief Investigator with input from a group of three art therapy experts (Health and Care Professions Council (HCPC) accredited art therapists working in National Health Service (NHS) medical contexts with experience of delivering art therapy - based staff support) and three experts by experience (Health Care professionals with experience of participating in art therapy - based staff support groups at work). Adherence to the intervention will be monitored through two adherence tools (therapist self reported and independent observer).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Healthcare professional employed in a patient facing clinical role by Barts Health NHS Trust or Barts Bank partners
Exclusion criteria
• Unwilling or unable to give consent
Primary purpose
Allocation
Interventional model
Masking
131 participants in 2 patient groups
Loading...
Central trial contact
Megan Tjasink; Stefan Priebe
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal